After facing some years of stagnation following the economic recession of 2008-2009, the Canadian pharmaceutical industry has been experiencing fluctuating growth since 2012. The industry maintained positive growth in 2014 and had total revenue of over USD 21 billion.
Led by the cardiovascular segment, the Canadian pharmaceutical industry is majorly dominated by foreign-owned multinationals. Over the years, the industry has become more favorable towards generic drugs as compared to its previous preference for branded drugs.
Aruvian Research analyzes the Canadian pharmaceutical industry in its research report – Canada Pharmaceutical Industry. The report is an in-depth analysis of the Canadian Pharmaceutical Industry landscape. The report begins with an introduction to the industry. We analyze the Canadian pharmaceutical industry through an industry definition, a SWOT analysis of the industry, industry statistics, size and structure analysis of the industry, industry growth analysis, market segments, drug sales in the industry, etc. The report also analyzes the industry's competitive landscape, market share of the leading players, major growth drivers in the industry and a profile of how Canada's pharmaceutical industry provides a cost advantage. Clinical trials and market access are other factors that are analyzed in the report.
Moving on to the analysis of OTC Pharmaceuticals in Canada, we analyze the market for OTC pharmaceuticals through an industry overview, industry growth by value, market segmentation, competitive landscape, market share of the major players, analysis of the major industry distribution channels and an industry forecast up to 2019.
The market for generic drugs in Canada is analyzed in a separate section. Generics market is analyzed through an industry overview, industry growth by value and volume both, geographical segmentation of the industry, competitive landscape prevalent in the market and an industry forecast up to 2019.
Regulations impacting the Canadian pharmaceutical industry is analyzed along with industry trends.
A Porter's Five Forces Framework analysis of the Canadian pharmaceutical industry analyzes the bargaining power of buyers and suppliers, competitive rivalry in the industry, the threat of new entrants and the threat of substitutes.
We also analyze the pricing and reimbursement system in the Canadian pharmaceutical industry along with re-import policies for drugs.
Pharmaceutical research and development in Canada is analyzed along with the impact of TRIPS on the Canadian pharmaceutical industry.
A forecast for the Canadian pharmaceutical industry is included till 2019.
Major industry players such as Allergan Plc, AstraZeneca Plc, Apotex Holdings, Sandoz, Johnson & Johnson, and many others are analyzed through a corporate profile, an analysis of their business segments, a financial analysis and a SWOT analysis.
Aruvian’s latest research is a collection of all you need to know about Canada’s Pharmaceutical Industry.